Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Verny

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
JAMA Neurology|July 4, 2017
Association Between Motor Symptoms and Brain Metabolism in Early Huntington DiseaseVéronique Gaura, Sonia Lavisse, Pierre Payoux, et al.
International Clinical Psychopharmacology|April 18, 2012
Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life InstrumentEmilie Clay, Annunziata De Nicola, Julie Dorey, et al.
Human Mutation|September 23, 2014
Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical dataMarc Ferré, Angélique Caignard, Dan Milea, et al.
Journal of Huntington'S Disease|February 20, 2025
Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimagingMarie Caillaud, Mickael Laisney, Alexandre Bejanin, et al.
Plos One|December 30, 2015
How to Capitalize on the Retest Effect in Future Trials on Huntington's DiseaseCatherine Schramm, Sandrine Katsahian, Katia Youssov, et al.
Experimental Neurology|September 21, 2010
Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutationsJulien Cassereau, Arnaud Chevrollier, Naïg Gueguen, et al.
Neurogenetics|July 21, 2009
Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A diseaseVirginie Guillet, Naïg Gueguen, Christophe Verny, et al.
Annals of Neurology|March 26, 2013
G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndromeSuzanne Lesage, Mathieu Anheim, Franck Letournel, et al.
Journal of the Peripheral Nervous System : JPNS|October 6, 2016
Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutationsPhilippe Codron, Arnaud Chevrollier, Mariame S Kane, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 1, 2018
Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesionsPhilippe Codron, Julien Cassereau, Patrick Vourc'h, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
JAMA Neurology|July 4, 2017
Association Between Motor Symptoms and Brain Metabolism in Early Huntington DiseaseVéronique Gaura, Sonia Lavisse, Pierre Payoux, et al.
International Clinical Psychopharmacology|April 18, 2012
Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life InstrumentEmilie Clay, Annunziata De Nicola, Julie Dorey, et al.
Human Mutation|September 23, 2014
Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical dataMarc Ferré, Angélique Caignard, Dan Milea, et al.
Journal of Huntington'S Disease|February 20, 2025
Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimagingMarie Caillaud, Mickael Laisney, Alexandre Bejanin, et al.
Plos One|December 30, 2015
How to Capitalize on the Retest Effect in Future Trials on Huntington's DiseaseCatherine Schramm, Sandrine Katsahian, Katia Youssov, et al.
Experimental Neurology|September 21, 2010
Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutationsJulien Cassereau, Arnaud Chevrollier, Naïg Gueguen, et al.
Neurogenetics|July 21, 2009
Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A diseaseVirginie Guillet, Naïg Gueguen, Christophe Verny, et al.
Annals of Neurology|March 26, 2013
G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndromeSuzanne Lesage, Mathieu Anheim, Franck Letournel, et al.
Journal of the Peripheral Nervous System : JPNS|October 6, 2016
Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutationsPhilippe Codron, Arnaud Chevrollier, Mariame S Kane, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 1, 2018
Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesionsPhilippe Codron, Julien Cassereau, Patrick Vourc'h, et al.
Pageof 10